#BEGIN_DRUGCARD DB03600

# AHFS_Codes:
Not Available

# ATC_Codes:
Not Available

# Absorption:
Not Available

# Biotransformation:
Not Available

# Brand_Mixtures:
Not Available

# Brand_Names:
Not Available

# CAS_Registry_Number:
334-48-5

# ChEBI_ID:
30813

# Chemical_Formula:
C10H20O2

# Chemical_IUPAC_Name:
decanoic acid

# Chemical_Structure:
Not Available

# Creation_Date:
2005-06-13 07:24:05 -0600

# DPD_Drug_ID_Number:
Not Available

# Description:
Not Available

# Dosage_Forms:
Not Available

# Drug_Category:
Antifungal Agents

# Drug_Interactions:
Not Available

# Drug_Reference:
Not Available

# Drug_Type:
Experimental
Small Molecule

# Experimental_Caco2_Permeability:
Not Available

# Experimental_LogP_Hydrophobicity:
4.09

# Experimental_Logs:
-3.44

# Experimental_Water_Solubility:
61.8 mg/L (at 25 °C)

# Food_Interactions:
Not Available

# GenBank_ID:
Not Available

# Generic_Name:
Decanoic Acid

# HET_ID:
DKA

# Half_Life:
Not Available

# InChI_Identifier:
InChI=1S/C10H20O2/c1-2-3-4-5-6-7-8-9-10(11)12/h2-9H2,1H3,(H,11,12)

# InChI_Key:
InChIKey=GHVNFZFCNZKVNT-UHFFFAOYSA-N

# Indication:
Not Available

# KEGG_Compound_ID:
C01571

# KEGG_Drug_ID:
Not Available

# LIMS_Drug_ID:
3600

# Mechanism_Of_Action:
Not Available

# Melting_Point:
31.9 °C

# Molecular_Weight_Avg:
172.2646

# Molecular_Weight_Mono:
172.146329884

# Organisms_Affected:
Not Available

# PDB_Experimental_ID:
1T5M

# PDB_Homology_ID:
Not Available

# PDRhealth_Link:
Not Available

# Pathways:
Not Available

# PharmGKB_ID:
Not Available

# Pharmacology:
Not Available

# Predicted_LogP_Hydrophobicity:
3.93

# Predicted_LogS:
-3.3

# Predicted_Water_Solubility:
9.46e-02 g/l

# Primary_Accession_No:
DB03600

# Protein_Binding:
Not Available

# PubChem_Compound_ID:
2969

# PubChem_Substance_ID:
46509055

# RxList_Link:
Not Available

# Salts:
Not Available

# Secondary_Accession_No:
DB03838
EXPT01213

# Smiles_String_canonical:
Not Available

# Smiles_String_isomeric:
CCCCCCCCCC(O)=O

# State:
solid

# Structure:
1

# SwissProt_ID:
Not Available

# SwissProt_Name:
Not Available

# Synonyms:
Capric acid

# Synthesis_Reference:
Not Available

# Toxicity:
Not Available

# Update_Date:
2013-02-08 16:22:25 -0700

# Wikipedia_Link:
Not Available

# pKa_Isoelectric_Point:
4.9

# Drug_Target_1_Cellular_Location:
Cytoplasm

# Drug_Target_1_Chromosome_Location:
Not Available

# Drug_Target_1_Drug_References:
10592235	Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42.
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_1_Essentiality:
Non-Essential

# Drug_Target_1_GenAtlas_ID:
Not Available

# Drug_Target_1_GenBank_ID_Gene:
M24427

# Drug_Target_1_GenBank_ID_Protein:
145884

# Drug_Target_1_GeneCard_ID:
Not Available

# Drug_Target_1_Gene_Name:
fabB

# Drug_Target_1_Gene_Sequence:
>1221 bp
ATGAAACGTGCAGTGATTACTGGCCTGGGCATTGTTTCCAGCATCGGTAATAACCAGCAG
GAAGTCCTGGCATCTCTGCGTGAAGGACGTTCAGGGATCACTTTCTCTCAGGAGCTGAAG
GATTCCGGCATGCGTAGCCACGTCTGGGGCAACGTAAAACTGGATACCACTGGCCTCATT
GACCGCAAAGTTGTGCGCTTTATGAGCGACGCATCCATTTATGCATTCCTTTCTATGGAG
CAGGCAATCGCTGATGCGGGCCTCTCTCCGGAAGCTTACCAGAATAACCCGCGCGTTGGC
CTGATTGCAGGTTCCGGCGGCGGCTCCCCGCGTTTCCAGGTGTTCGGCGCTGACGCAATG
CGCGGCCCGCGCGGCCTGAAAGCGGTTGGCCCGTATGTGGTCACCAAAGCGATGGCATCC
GGCGTTTCTGCCTGCCTCGCCACCCCGTTTAAAATTCATGGCGTTAACTACTCCATCAGC
TCCGCGTGTGCGACTTCCGCACACTGTATCGGTAACGCAGTAGAGCAGATCCAACTGGGC
AAACAGGACATCGTGTTTGCTGGCGGCGGCGAAGAGCTGTGCTGGGAAATGGCTTGCGAA
TTCGACGCAATGGGTGCGCTGTCTACTAAATACAACGACACCCCGGAAAAAGCCTCCCGT
ACTTACGACGCTCACCGTGACGGTTTCGTTATCGCTGGCGGCGGCGGTATGGTAGTGGTT
GAAGAGCTGGAACACGCGCTGGCGCGTGGTGCTCACATCTATGCTGAAATCGTTGGCTAC
GGCGCAACCTCTGATGGTGCAGACATGGTTGCTCCGTCTGGCGAAGGCGCAGTACGCTGC
ATGAAGATGGCGATGCATGGCGTTGATACCCCAATCGATTACCTGAACTCCCACGGTACT
TCGACTCCGGTTGGCGACGTGAAAGAGCTGGCAGCTATCCGTGAAGTGTTCGGCGATAAG
AGCCCGGCGATTTCTGCAACCAAAGCCATGACCGGTCACTCTCTGGGCGCTGCTGGCGTA
CAGGAAGCTATCTACTCTCTGCTGATGCTGGAACACGGCTTCATCGCCCCGAGCATCAAC
ATTGAAGAGCTGGACGAGCAGGCTGCAGGTCTGAACATCGTGACCGAAACGACCGATCGC
GAACTGACCACCGTTATGTCTAACAGCTTCGGCTTCGGCGGCACCAACGCCACGCTGGTA
ATGCGCAAGCTGAAAGATTAA

# Drug_Target_1_General_Function:
Lipid transport and metabolism

# Drug_Target_1_General_References:
10571059	Olsen JG, Kadziola A, von Wettstein-Knowles P, Siggaard-Andersen M, Lindquist Y, Larsen S: The X-ray crystal structure of beta-ketoacyl [acyl carrier protein] synthase I. FEBS Lett. 1999 Oct 22;460(1):46-52.
3076376	Kauppinen S, Siggaard-Andersen M, von Wettstein-Knowles P: beta-Ketoacyl-ACP synthase I of Escherichia coli: nucleotide sequence of the fabB gene and identification of the cerulenin binding residue. Carlsberg Res Commun. 1988;53(6):357-70.
3076377	Siggaard-Andersen M: Role of Escherichia coli beta-ketoacyl-ACP synthase I in unsaturated fatty acid synthesis. Carlsberg Res Commun. 1988;53(6):371-9.
9205837	Yamamoto Y, Aiba H, Baba T, Hayashi K, Inada T, Isono K, Itoh T, Kimura S, Kitagawa M, Makino K, Miki T, Mitsuhashi N, Mizobuchi K, Mori H, Nakade S, Nakamura Y, Nashimoto H, Oshima T, Oyama S, Saito N, Sampei G, Satoh Y, Sivasundaram S, Tagami H, Horiuchi T, et al.: Construction of a contiguous 874-kb sequence of the Escherichia coli -K12 genome corresponding to 50.0-68.8 min on the linkage map and analysis of its sequence features. DNA Res. 1997 Apr 28;4(2):91-113.
9278503	Blattner FR, Plunkett G 3rd, Bloch CA, Perna NT, Burland V, Riley M, Collado-Vides J, Glasner JD, Rode CK, Mayhew GF, Gregor J, Davis NW, Kirkpatrick HA, Goeden MA, Rose DJ, Mau B, Shao Y: The complete genome sequence of Escherichia coli K-12. Science. 1997 Sep 5;277(5331):1453-74.

# Drug_Target_1_HGNC_ID:
Not Available

# Drug_Target_1_HPRD_ID:
Not Available

# Drug_Target_1_ID:
889

# Drug_Target_1_Locus:
Not Available

# Drug_Target_1_Molecular_Weight:
42614

# Drug_Target_1_Name:
3-oxoacyl-[acyl-carrier-protein] synthase 1

# Drug_Target_1_Number_of_Residues:
406

# Drug_Target_1_PDB_ID:
1G5X

# Drug_Target_1_Pathway:
Not Available

# Drug_Target_1_Pfam_Domain_Function:
PF00109	ketoacyl-synt
PF02801	Ketoacyl-synt_C

# Drug_Target_1_Protein_Sequence:
>3-oxoacyl-[acyl-carrier-protein] synthase 1
MKRAVITGLGIVSSIGNNQQEVLASLREGRSGITFSQELKDSGMRSHVWGNVKLDTTGLI
DRKVVRFMSDASIYAFLSMEQAIADAGLSPEAYQNNPRVGLIAGSGGGSPRFQVFGADAM
RGPRGLKAVGPYVVTKAMASGVSACLATPFKIHGVNYSISSACATSAHCIGNAVEQIQLG
KQDIVFAGGGEELCWEMACEFDAMGALSTKYNDTPEKASRTYDAHRDGFVIAGGGGMVVV
EELEHALARGAHIYAEIVGYGATSDGADMVAPSGEGAVRCMKMAMHGVDTPIDYLNSHGT
STPVGDVKELAAIREVFGDKSPAISATKAMTGHSLGAAGVQEAIYSLLMLEHGFIAPSIN
IEELDEQAAGLNIVTETTDRELTTVMSNSFGFGGTNATLVMRKLKD

# Drug_Target_1_Reaction:
an acyl-[acyl-carrier-protein] + malonyl-[acyl-carrier-protein] = a 3-oxoacyl-[acyl-carrier-protein] + CO2 + [acyl-carrier-protein]

# Drug_Target_1_Signals:
None

# Drug_Target_1_Specific_Function:
Catalyzes the condensation reaction of fatty acid synthesis by the addition to an acyl acceptor of two carbons from malonyl-ACP. Specific for elongation from C-10 to unsaturated C-16 and C-18 fatty acids

# Drug_Target_1_SwissProt_ID:
P0A953

# Drug_Target_1_SwissProt_Name:
FABB_ECOLI

# Drug_Target_1_Synonyms:
3-oxoacyl- [acyl-carrier-protein] synthase I
Beta-ketoacyl-ACP synthase I
EC 2.3.1.41
KAS I

# Drug_Target_1_Theoretical_pI:
5.25

# Drug_Target_1_Transmembrane_Regions:
None

# Drug_Target_2_Cellular_Location:
Golgi apparatus

# Drug_Target_2_Chromosome_Location:
Not Available

# Drug_Target_2_Drug_References:
10592235	Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42.

# Drug_Target_2_Essentiality:
Non-Essential

# Drug_Target_2_GenAtlas_ID:
FURIN

# Drug_Target_2_GenBank_ID_Gene:
X17094

# Drug_Target_2_GenBank_ID_Protein:
Not Available

# Drug_Target_2_GeneCard_ID:
Not Available

# Drug_Target_2_Gene_Name:
FURIN

# Drug_Target_2_Gene_Sequence:
>2385 bp
ATGGAGCTGAGGCCCTGGTTGCTATGGGTGGTAGCAGCAACAGGAACCTTGGTCCTGCTA
GCAGCTGATGCTCAGGGCCAGAAGGTCTTCACCAACACGTGGGCTGTGCGCATCCCTGGA
GGCCCAGCGGTGGCCAACAGTGTGGCACGGAAGCATGGGTTCCTCAACCTGGGCCAGATC
TTCGGGGACTATTACCACTTCTGGCATCGAGGAGTGACGAAGCGGTCCCTGTCGCCTCAC
CGCCCGCGGCACAGCCGGCTGCAGAGGGAGCCTCAAGTACAGTGGCTGGAACAGCAGGTG
GCAAAGCGACGGACTAAACGGGACGTGTACCAGGAGCCCACAGACCCCAAGTTTCCTCAG
CAGTGGTACCTGTCTGGTGTCACTCAGCGGGACCTGAATGTGAAGGCGGCCTGGGCGCAG
GGCTACACAGGGCACGGCATTGTGGTCTCCATTCTGGACGATGGCATCGAGAAGAACCAC
CCGGACTTGGCAGGCAATTATGATCCTGGGGCCAGTTTTGATGTCAATGACCAGGACCCT
GACCCCCAGCCTCGGTACACACAGATGAATGACAACAGGCACGGCACACGGTGTGCGGGG
GAAGTGGCTGCGGTGGCCAACAACGGTGTCTGTGGTGTAGGTGTGGCCTACAACGCCCGC
ATTGGAGGGGTGCGCATGCTGGATGGCGAGGTGACAGATGCAGTGGAGGCACGCTCGCTG
GGCCTGAACCCCAACCACATCCACATCTACAGTGCCAGCTGGGGCCCCGAGGATGACGGC
AAGACAGTGGATGGGCCAGCCCGCCTCGCCGAGGAGGCCTTCTTCCGTGGGGTTAGCCAG
GGCCGAGGGGGGCTGGGCTCCATCTTTGTCTGGGCCTCGGGGAACGGGGGCCGGGAACAT
GACAGCTGCAACTGCGACGGCTACACCAACAGTATCTACACGCTGTCCATCAGCAGCGCC
ACGCAGTTTGGCAACGTGCCGTGGTACAGCGAGGCCTGCTCGTCCACACTGGCCACGACC
TACAGCAGTGGCAACCAGAATGAGAAGCAGATCGTGACGACTGACTTGCGGCAGAAGTGC
ACGGAGTCTCACACGGGCACCTCAGCCTCTGCCCCCTTAGCAGCCGGCATCATTGCTCTC
ACCCTGGAGGCCAATAAGAACCTCACATGGCGGGACATGCAACACCTGGTGGTACAGACC
TCGAAGCCAGCCCACCTCAATGCCAACGACTGGGCCACCAATGGTGTGGGCCGGAAAGTG
AGCCACTCATATGGCTACGGGCTTTTGGACGCAGGCGCCATGGTGGCCCTGGCCCAGAAT
TGGACCACAGTGGCCCCCCAGCGGAAGTGCATCATCGACATCCTCACCGAGCCCAAAGAC
ATCGGGAAACGGCTCGAGGTGCGGAAGACCGTGACCGCGTGCCTGGGCGAGCCCAACCAC
ATCACTCGGCTGGAGCACGCTCAGGCGCGGCTCACCCTGTCCTATAATCGCCGTGGCGAC
CTGGCCATCCACCTGGTCAGCCCCATGGGCACCCGCTCCACCCTGCTGGCAGCCAGGCCA
CATGACTACTCCGCAGATGGGTTTAATGACTGGGCCTTCATGACAACTCATTCCTGGGAT
GAGGATCCCTCTGGCGAGTGGGTCCTAGAGATTGAAAACACCAGCGAAGCCAACAACTAT
GGGACGCTGACCAAGTTCACCCTCGTACTCTATGGCACCGCCCCTGAGGGGCTGCCCGTA
CCTCCAGAAAGCAGTGGCTGCAAGACCCTCACGTCCAGTCAGGCCTGTGTGGTGTGCGAG
GAAGGCTTCTCCCTGCACCAGAAGAGCTGTGTCCAGCACTGCCCTCCAGGCTTCGCCCCC
CAAGTCCTCGATACGCACTATAGCACCGAGAATGACGTGGAGACCATCCGGGCCAGCGTC
TGCGCCCCCTGCCACGCCTCATGTGCCACATGCCAGGGGCCGGCCCTGACAGACTGCCTC
AGCTGCCCCAGCCACGCCTCCTTGGACCCTGTGGAGCAGACTTGCTCCCGGCAAAGCCAG
AGCAGCCGAGAGTCCCCGCCACAGCAGCAGCCACCTCGGCTGCCCCCGGAGGTGGAGGCG
GGGCAACGGCTGCGGGCAGGGCTGCTGCCCTCACACCTGCCTGAGGTGGTGGCCGGCCTC
AGCTGCGCCTTCATCGTGCTGGTCTTCGTCACTGTCTTCCTGGTCCTGCAGCTGCGCTCT
GGCTTTAGTTTTCGGGGGGTGAAGGTGTACACCATGGACCGTGGCCTCATCTCCTACAAG
GGGCTGCCCCCTGAAGCCTGGCAGGAGGAGTGCCCGTCTGACTCAGAAGAGGACGAGGGC
CGGGGCGAGAGGACCGCCTTTATCAAAGACCAGAGCGCCCTCTGA

# Drug_Target_2_General_Function:
Involved in subtilase activity

# Drug_Target_2_General_References:
1629222	Leduc R, Molloy SS, Thorne BA, Thomas G: Activation of human furin precursor processing endoprotease occurs by an intramolecular autoproteolytic cleavage. J Biol Chem. 1992 Jul 15;267(20):14304-8.
1713771	Barr PJ, Mason OB, Landsberg KE, Wong PA, Kiefer MC, Brake AJ: cDNA and gene structure for a human subtilisin-like protease with cleavage specificity for paired basic amino acid residues. DNA Cell Biol. 1991 Jun;10(5):319-28.
2251280	Wise RJ, Barr PJ, Wong PA, Kiefer MC, Brake AJ, Kaufman RJ: Expression of a human proprotein processing enzyme: correct cleavage of the von Willebrand factor precursor at a paired basic amino acid site. Proc Natl Acad Sci U S A. 1990 Dec;87(23):9378-82.
2408021	van den Ouweland AM, van Duijnhoven HL, Keizer GD, Dorssers LC, Van de Ven WJ: Structural homology between the human fur gene product and the subtilisin-like protease encoded by yeast KEX2. Nucleic Acids Res. 1990 Feb 11;18(3):664.
2674906	Van den Ouweland AM, Van Groningen JJ, Roebroek AJ, Onnekink C, Van de Ven WJ: Nucleotide sequence analysis of the human fur gene. Nucleic Acids Res. 1989 Sep 12;17(17):7101-2.
3023061	Roebroek AJ, Schalken JA, Leunissen JA, Onnekink C, Bloemers HP, Van de Ven WJ: Evolutionary conserved close linkage of the c-fes/fps proto-oncogene and genetic sequences encoding a receptor-like protein. EMBO J. 1986 Sep;5(9):2197-202.
7690548	Takahashi S, Kasai K, Hatsuzawa K, Kitamura N, Misumi Y, Ikehara Y, Murakami K, Nakayama K: A mutation of furin causes the lack of precursor-processing activity in human colon carcinoma LoVo cells. Biochem Biophys Res Commun. 1993 Sep 15;195(2):1019-26.
8020465	Siezen RJ, Creemers JW, Van de Ven WJ: Homology modelling of the catalytic domain of human furin. A model for the eukaryotic subtilisin-like proprotein convertases. Eur J Biochem. 1994 Jun 1;222(2):255-66.
8846780	Jones BG, Thomas L, Molloy SS, Thulin CD, Fry MD, Walsh KA, Thomas G: Intracellular trafficking of furin is modulated by the phosphorylation state of a casein kinase II site in its cytoplasmic tail. EMBO J. 1995 Dec 1;14(23):5869-83.

# Drug_Target_2_HGNC_ID:
HGNC:8568

# Drug_Target_2_HPRD_ID:
Not Available

# Drug_Target_2_ID:
4161

# Drug_Target_2_Locus:
15q26.1

# Drug_Target_2_Molecular_Weight:
86679

# Drug_Target_2_Name:
Furin

# Drug_Target_2_Number_of_Residues:
794

# Drug_Target_2_PDB_ID:
1P8J

# Drug_Target_2_Pathway:
Not Available

# Drug_Target_2_Pfam_Domain_Function:
PF00082	Peptidase_S8
PF01483	P_proprotein

# Drug_Target_2_Protein_Sequence:
>Furin
MELRPWLLWVVAATGTLVLLAADAQGQKVFTNTWAVRIPGGPAVANSVARKHGFLNLGQI
FGDYYHFWHRGVTKRSLSPHRPRHSRLQREPQVQWLEQQVAKRRTKRDVYQEPTDPKFPQ
QWYLSGVTQRDLNVKAAWAQGYTGHGIVVSILDDGIEKNHPDLAGNYDPGASFDVNDQDP
DPQPRYTQMNDNRHGTRCAGEVAAVANNGVCGVGVAYNARIGGVRMLDGEVTDAVEARSL
GLNPNHIHIYSASWGPEDDGKTVDGPARLAEEAFFRGVSQGRGGLGSIFVWASGNGGREH
DSCNCDGYTNSIYTLSISSATQFGNVPWYSEACSSTLATTYSSGNQNEKQIVTTDLRQKC
TESHTGTSASAPLAAGIIALTLEANKNLTWRDMQHLVVQTSKPAHLNANDWATNGVGRKV
SHSYGYGLLDAGAMVALAQNWTTVAPQRKCIIDILTEPKDIGKRLEVRKTVTACLGEPNH
ITRLEHAQARLTLSYNRRGDLAIHLVSPMGTRSTLLAARPHDYSADGFNDWAFMTTHSWD
EDPSGEWVLEIENTSEANNYGTLTKFTLVLYGTAPEGLPVPPESSGCKTLTSSQACVVCE
EGFSLHQKSCVQHCPPGFAPQVLDTHYSTENDVETIRASVCAPCHASCATCQGPALTDCL
SCPSHASLDPVEQTCSRQSQSSRESPPQQQPPRLPPEVEAGQRLRAGLLPSHLPEVVAGL
SCAFIVLVFVTVFLVLQLRSGFSFRGVKVYTMDRGLISYKGLPPEAWQEECPSDSEEDEG
RGERTAFIKDQSAL

# Drug_Target_2_Reaction:
Not Available

# Drug_Target_2_Signals:
1-24

# Drug_Target_2_Specific_Function:
Furin is likely to represent the ubiquitous endoprotease activity within constitutive secretory pathways and capable of cleavage at the RX(K/R)R consensus motif

# Drug_Target_2_SwissProt_ID:
P09958

# Drug_Target_2_SwissProt_Name:
FURIN_HUMAN

# Drug_Target_2_Synonyms:
Dibasic-processing enzyme
EC 3.4.21.75
Furin precursor
PACE
Paired basic amino acid residue cleaving enzyme

# Drug_Target_2_Theoretical_pI:
6.44

# Drug_Target_2_Transmembrane_Regions:
716-738

# Drug_Target_3_Cellular_Location:
Secreted, cell wall

# Drug_Target_3_Chromosome_Location:
Not Available

# Drug_Target_3_Drug_References:
10592235	Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42.

# Drug_Target_3_Essentiality:
Essential

# Drug_Target_3_GenAtlas_ID:
Not Available

# Drug_Target_3_GenBank_ID_Gene:
X77864

# Drug_Target_3_GenBank_ID_Protein:
4388777

# Drug_Target_3_GeneCard_ID:
pab

# Drug_Target_3_Gene_Name:
pab

# Drug_Target_3_Gene_Sequence:
>1164 bp
ATGAAACTTAATAAGAAATTATTAATGGCTGCACTAGCAGGTGCAATTGTAGTAGGTGGC
GGAGTTAATACATTCGCAGCTGATGAACCTGGCGCAATAAAAGTAGACAAAGCTCCAGAA
GCTCCTAGTCAAGAACTTAAACTAACTAAAGAAGAAGCTGAAAAGGCTCTTAAAAAAGAA
AAGCCAATAGCAAAAGAAAGATTAAGAAGACTTGGAATTACAAGCGAATTTATTCTTAAT
CAAATAGACAAAGCTACATCTAGAGAAGGATTAGAAAGTTTAGTTCAAACTATAAAACAA
TCATACCTTAAAGACCATCCTATCAAAGAAGAAAAAACAGAAGAAACACCAAAATATAAT
AACCTATTCGATAAACATGAATTAGGAGGATTAGGAAAAGACAAAGGCCCTGGAAGATTC
GATGAGAACGGATGGGAAAACAACGAACATGGATATGAAACTAGAGAAAACGCTGAAAAA
GCTGCAGTAAAAGCACTAGGCGATAAAGAAATTAATAAATCATATACTATTTCACAAGGT
GTAGATGGAAGATACTACTATGTATTATCTAGAGAAGAAGCTGAAACTCCTAAAAAACCT
GAAGAAAAGAAACCTGAAGATAAAAGACCAAAAATGACAATTGATCAATGGTTATTAAAG
AACGCTAAAGAAGATGCAATCGCAGAATTAAAAAAAGCTGGAATCACATCTGATTTCTAC
TTCAATGCAATTAACAAAGCAAAAACAGTTGAAGAAGTTAATGCTTTAAAGAACGAAATT
TTAAAAGCACACGCTGGTAAGGAAGTAAACCCATCAACTCCTGAAGTAACTCCATCAGTT
CCACAAAACCACTACCATGAAAACGACTATGCTAACATAGGCGCAGGTGAAGGTACTAAA
GAAGACGGTAAGAAGGAAAATTCCAAAGAAGGAATCAAAAGGAAAACGGCAAGGGAAGAA
AAACCTGGTAAAGAAGAAAAACCAGCAAAAGAAGACAAGAAAGAAAACAAAAAGAAAGAA
AACACTGATTCTCCAAACAAGAAGAAAAAAGAAAAAGCTGCATTACCAGAAGCTGGTAGG
CGGAAGGCTGAAATCTTAACATTAGCAGCAGCTTCATTATCAAGCGTTGCAGGTGCTTTC
ATTTCACTTAAAAAACGTAAATAA

# Drug_Target_3_General_Function:
Involved in protein binding

# Drug_Target_3_General_References:
8163519	de Chateau M, Bjorck L: Protein PAB, a mosaic albumin-binding bacterial protein representing the first contemporary example of module shuffling. J Biol Chem. 1994 Apr 22;269(16):12147-51.
9086265	Johansson MU, de Chateau M, Wikstrom M, Forsen S, Drakenberg T, Bjorck L: Solution structure of the albumin-binding GA module: a versatile bacterial protein domain. J Mol Biol. 1997 Mar 14;266(5):859-65.

# Drug_Target_3_HGNC_ID:
Not Available

# Drug_Target_3_HPRD_ID:
Not Available

# Drug_Target_3_ID:
6541

# Drug_Target_3_Locus:
Not Available

# Drug_Target_3_Molecular_Weight:
43057.4

# Drug_Target_3_Name:
Peptostreptococcal albumin-binding protein

# Drug_Target_3_Number_of_Residues:
387

# Drug_Target_3_PDB_ID:
1PRB

# Drug_Target_3_Pathway:
Not Available

# Drug_Target_3_Pfam_Domain_Function:
PF00746	Gram_pos_anchor
PF01468	GA

# Drug_Target_3_Protein_Sequence:
>Peptostreptococcal albumin-binding protein
MKLNKKLLMAALAGAIVVGGGVNTFAADEPGAIKVDKAPEAPSQELKLTKEEAEKALKKE
KPIAKERLRRLGITSEFILNQIDKATSREGLESLVQTIKQSYLKDHPIKEEKTEETPKYN
NLFDKHELGGLGKDKGPGRFDENGWENNEHGYETRENAEKAAVKALGDKEINKSYTISQG
VDGRYYYVLSREEAETPKKPEEKKPEDKRPKMTIDQWLLKNAKEDAIAELKKAGITSDFY
FNAINKAKTVEEVNALKNEILKAHAGKEVNPSTPEVTPSVPQNHYHENDYANIGAGEGTK
EDGKKENSKEGIKRKTAREEKPGKEEKPAKEDKKENKKKENTDSPNKKKKEKAALPEAGR
RKAEILTLAAASLSSVAGAFISLKKRK

# Drug_Target_3_Reaction:
Not Available

# Drug_Target_3_Signals:
1-26

# Drug_Target_3_Specific_Function:
Binds serum albumin

# Drug_Target_3_SwissProt_ID:
Q51911

# Drug_Target_3_SwissProt_Name:
PAB_PEPMA

# Drug_Target_3_Synonyms:
Not Available

# Drug_Target_3_Theoretical_pI:
9.79

# Drug_Target_3_Transmembrane_Regions:
None

# Drug_Target_4_Cellular_Location:
Cytoplasm

# Drug_Target_4_Chromosome_Location:
Not Available

# Drug_Target_4_Drug_References:
10592235	Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42.

# Drug_Target_4_Essentiality:
Non-Essential

# Drug_Target_4_GenAtlas_ID:
GLTP

# Drug_Target_4_GenBank_ID_Gene:
AF209704

# Drug_Target_4_GenBank_ID_Protein:
6959686

# Drug_Target_4_GeneCard_ID:
GLTP

# Drug_Target_4_Gene_Name:
GLTP

# Drug_Target_4_Gene_Sequence:
>630 bp
ATGGCGCTGCTGGCGGAGCACTTGCTGAAGCCGCTGCCCGCGGACAAGCAGATCGAGACC
GGGCCCTTCCTCGAGGCGGTGTCCCACCTGCCGCCCTTCTTCGATTGCCTTGGGTCCCCA
GTGTTTACTCCCATCAAGGCAGACATAAGCGGCAACATCACGAAAATCAAAGCTGTGTAC
GACACCAACCCAGCCAAGTTCCGGACCCTGCAGAACATCCTGGAGGTGGAGAAAGAAATG
TATGGAGCAGAGTGGCCCAAAGTAGGGGCCACACTGGCGCTGATGTGGCTGAAAAGAGGC
CTCCGCTTCATCCAGGTCTTCCTCCAGAGCATCTGCGACGGGGAGCGGGACGAGAACCAC
CCCAACCTCATCCGTGTCAACGCCACCAAGGCCTACGAGATGGCCCTCAAGAAGTACCAT
GGCTGGATCGTGCAGAAGATCTTCCAGGCAGCACTGTACGCAGCACCCTATAAGTCTGAC
TTCCTGAAAGCGCTCTCCAAGGGGCAGAATGTTACGGAGGAGGAGTGCCTGGAGAAGATC
CGCCTCTTCCTAGTCAACTACACGGCGACCATCGATGTCATCTACGAGATGTACACCCAG
ATGAACGCTGAGCTCAACTACAAGGTGTAG

# Drug_Target_4_General_Function:
Involved in glycolipid binding

# Drug_Target_4_General_References:
Not Available

# Drug_Target_4_HGNC_ID:
HGNC:24867

# Drug_Target_4_HPRD_ID:
16409

# Drug_Target_4_ID:
3382

# Drug_Target_4_Locus:
12q24.11

# Drug_Target_4_Molecular_Weight:
23850

# Drug_Target_4_Name:
Glycolipid transfer protein

# Drug_Target_4_Number_of_Residues:
209

# Drug_Target_4_PDB_ID:
1SX6

# Drug_Target_4_Pathway:
Not Available

# Drug_Target_4_Pfam_Domain_Function:
Not Available

# Drug_Target_4_Protein_Sequence:
>Glycolipid transfer protein
MALLAEHLLKPLPADKQIETGPFLEAVSHLPPFFDCLGSPVFTPIKADISGNITKIKAVY
DTNPAKFRTLQNILEVEKEMYGAEWPKVGATLALMWLKRGLRFIQVFLQSICDGERDENH
PNLIRVNATKAYEMALKKYHGWIVQKIFQAALYAAPYKSDFLKALSKGQNVTEEECLEKI
RLFLVNYTATIDVIYEMYTQMNAELNYKV

# Drug_Target_4_Reaction:
Not Available

# Drug_Target_4_Signals:
None

# Drug_Target_4_Specific_Function:
Accelerates the intermembrane transfer of various glycolipids. Catalyzes the transfer of various glycosphingolipids and glyceroglycolipids between membranes but does not catalyze the transfer of phospholipids. It is possible that it is involved in the intracellular translocation of glucosylceramides

# Drug_Target_4_SwissProt_ID:
Q9NZD2

# Drug_Target_4_SwissProt_Name:
GLTP_HUMAN

# Drug_Target_4_Synonyms:
GLTP

# Drug_Target_4_Theoretical_pI:
7.49

# Drug_Target_4_Transmembrane_Regions:
None

# Drug_Target_5_Cellular_Location:
Not Available

# Drug_Target_5_Chromosome_Location:
Not Available

# Drug_Target_5_Drug_References:
10592235	Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42.

# Drug_Target_5_Essentiality:
Non-Essential

# Drug_Target_5_GenAtlas_ID:
Not Available

# Drug_Target_5_GenBank_ID_Gene:
Not Available

# Drug_Target_5_GenBank_ID_Protein:
Not Available

# Drug_Target_5_GeneCard_ID:
Not Available

# Drug_Target_5_Gene_Name:
lipB

# Drug_Target_5_Gene_Sequence:
Not Available

# Drug_Target_5_General_Function:
Not Available

# Drug_Target_5_General_References:
Not Available

# Drug_Target_5_HGNC_ID:
Not Available

# Drug_Target_5_HPRD_ID:
Not Available

# Drug_Target_5_ID:
6542

# Drug_Target_5_Locus:
Not Available

# Drug_Target_5_Molecular_Weight:
Not Available

# Drug_Target_5_Name:
Octanoyltransferase

# Drug_Target_5_Number_of_Residues:
0

# Drug_Target_5_PDB_ID:
Not Available

# Drug_Target_5_Pathway:
Not Available

# Drug_Target_5_Pfam_Domain_Function:
Not Available

# Drug_Target_5_Protein_Sequence:
Not Available

# Drug_Target_5_Reaction:
Not Available

# Drug_Target_5_Signals:
Not Available

# Drug_Target_5_Specific_Function:
Not Available

# Drug_Target_5_SwissProt_ID:
Q10404

# Drug_Target_5_SwissProt_Name:
LIPB_MYCTU

# Drug_Target_5_Synonyms:
Not Available

# Drug_Target_5_Theoretical_pI:
Not Available

# Drug_Target_5_Transmembrane_Regions:
Not Available

# Drug_Target_6_Cellular_Location:
Not Available

# Drug_Target_6_Chromosome_Location:
Not Available

# Drug_Target_6_Drug_References:
10592235	Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42.

# Drug_Target_6_Essentiality:
Essential

# Drug_Target_6_GenAtlas_ID:
Not Available

# Drug_Target_6_GenBank_ID_Gene:
AJ605139

# Drug_Target_6_GenBank_ID_Protein:
40713133

# Drug_Target_6_GeneCard_ID:
tcp14

# Drug_Target_6_Gene_Name:
tcp14

# Drug_Target_6_Gene_Sequence:
>1131 bp
ATGTCGACCGGAATCGCGGTGGCCGCCGTCGCCGCCACCGCCGGATCCGCCTCCGCGAGC
CCCGCTCTCGCCGCCGCGCCGCCCGCGACGGTGGCCGCCGGTTACGCGCACACCTGCGCG
ATCCGGACCGGCGGGACCCTGTGGTGCTGGGGCTCCAACGCCAACGGCCAGCTCGGCGAC
GGCACGAAGACCAGCCGCACCACCGCGGTACGGGTCGGCGACGCCACCACGTGGGCCGGC
GTCGACGCCGGCACCAGCCACAACTGCGCGGTCCGGACGGACGGCACGCTGTGGTGCTGG
GGCAGCAACAGCCGCGGCCAGCTCGGCGACGGCAGCACCACCGACCGCACCGCCCCGGTC
CGCGTCGGCACCGCGACGAACTGGACCACGGTCAGCGCCGGCGACCGGCACACCTGCGCG
GTGCGTACCGACGGGACCCTGTGGTGCTGGGGCTTCAACCGGCTGGGGCAGCTCGGCGAC
GGCGCGCAGGTCTACGTCGCCACCACCCCGCTGCAGGTCGGCACGGCGAGCACCTGGGCG
AGCGTCACCACCGGTTTCGCGCACACCTGCGGGACGCGCACCGACGGCACCCTGTGGTGC
TGGGGCGACAGCTCGGCCGGGCAGCTCGGCCTCGGCATCCTCAGCTACCGGACCACCCCG
GGGCAGGTCGGCACCGCGACGAACTGGGCCACCGTGACCGCCGGGTACACCTTCACCTGC
GCGACCCGCACCGACGGCACCCTGTGGTGCTTCGGCGAGAACGGGTACGGCCAGCTCGGC
GTCACCGGCACGTACCAGGCGTCGCCGGTGCAGGTCGGCAGCGTGGCGACGTGGACCGGC
GTCGCGGCCGGCTTCGACACGGCGTGCGCGTCCCGCGCCGACGGCAGCCTGTGGTGCTGG
GGCAACAACGCGGCCGGGCAGATCGGCGACGGCACCACGACGCACCGCTACGCCCCGACC
CGGGTCGGCACCGCGACCACCTGGACGGCCGCCCTCGCGGCCGGCTACCACAACTGCGGC
TTCCGGACCGACGACAGCCTGTGGTGCTGGGGCAGCAACGCCAACGGGGAGCTCGGCGAC
GGCACCACCACCGCGCGCCCGGCCCCGCAGCAGGTGAGCCTGCCGGCCTGA

# Drug_Target_6_General_Function:
Not Available

# Drug_Target_6_General_References:
14702401	Sosio M, Kloosterman H, Bianchi A, de Vreugd P, Dijkhuizen L, Donadio S: Organization of the teicoplanin gene cluster in Actinoplanes teichomyceticus. Microbiology. 2004 Jan;150(Pt 1):95-102.
15113000	Li TL, Huang F, Haydock SF, Mironenko T, Leadlay PF, Spencer JB: Biosynthetic gene cluster of the glycopeptide antibiotic teicoplanin: characterization of two glycosyltransferases and the key acyltransferase. Chem Biol. 2004 Jan;11(1):107-19.

# Drug_Target_6_HGNC_ID:
Not Available

# Drug_Target_6_HPRD_ID:
Not Available

# Drug_Target_6_ID:
6543

# Drug_Target_6_Locus:
Not Available

# Drug_Target_6_Molecular_Weight:
30067.2

# Drug_Target_6_Name:
Putative uncharacterized protein

# Drug_Target_6_Number_of_Residues:
273

# Drug_Target_6_PDB_ID:
Not Available

# Drug_Target_6_Pathway:
Not Available

# Drug_Target_6_Pfam_Domain_Function:
PF02585	PIG-L

# Drug_Target_6_Protein_Sequence:
>Putative uncharacterized protein
MPHDPGATRLLAISPHLDDAVLSFGAGLAQAAQDGANVLVYTVFAGAAQPPYSPAAQRMH
TIWGLAPDDDAVLYRRKEDIAALDHLRVAHRHGRFLDSIYRKLPDGRWLTAHVEGRQKLA
VNDHSPDSDHDLVGEVADDIRSIIDEFDPTLVVTCAAIGEHPDHEATRDAALFATHEKNV
PVRLWEDLPYAVFKSGAVELPQGFRLGSADVSSVKPEMRSQKFQAVERYSSQMVLLNGSE
NNLFDRLDEHARQNAPHGGYGETTWPVVRSDDS

# Drug_Target_6_Reaction:
Not Available

# Drug_Target_6_Signals:
None

# Drug_Target_6_Specific_Function:
Not Available

# Drug_Target_6_SwissProt_ID:
Q6ZZJ1

# Drug_Target_6_SwissProt_Name:
Q6ZZJ1_ACTTI

# Drug_Target_6_Synonyms:
SubName: Putative uncharacterized protein tcp14

# Drug_Target_6_Theoretical_pI:
5.31

# Drug_Target_6_Transmembrane_Regions:
None

#END_DRUGCARD DB03600
